ProQR Therapeutics N.V (NASDAQ: PRQR) on Tuesday, soared 9.43% from the previous trading day, before settling in for the closing price of $2.12. Within the past 52 weeks, PRQR’s price has moved between $1.07 and $3.71.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 25.70%. The company achieved an average annual earnings per share of -31.01%. With a float of $70.02 million, this company’s outstanding shares have now reached $105.35 million.
ProQR Therapeutics N.V (PRQR) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of ProQR Therapeutics N.V is 33.45%, while institutional ownership is 35.10%.
ProQR Therapeutics N.V (PRQR) Latest Financial update
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.1 earnings per share (EPS) for the period topping the consensus outlook (set at -0.15) by 0.05. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.14 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -31.01% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -22.04% during the next five years compared to 25.70% growth over the previous five years of trading.
ProQR Therapeutics N.V (NASDAQ: PRQR) Trading Performance Indicators
ProQR Therapeutics N.V (PRQR) is currently performing well based on its current performance indicators. A quick ratio of 3.36 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 14.32.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.46, a number that is poised to hit -0.12 in the next quarter and is forecasted to reach -0.62 in one year’s time.
Technical Analysis of ProQR Therapeutics N.V (PRQR)
The latest stats from [ProQR Therapeutics N.V, PRQR] show that its last 5-days average volume of 0.92 million was superior to 0.44 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 53.33%.
During the past 100 days, ProQR Therapeutics N.V’s (PRQR) raw stochastic average was set at 40.00%, which indicates a significant decrease from 80.39% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.18 in the past 14 days, which was higher than the 0.17 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.38, while its 200-day Moving Average is $2.01. Now, the first resistance to watch is $2.45. This is followed by the second major resistance level at $2.59. The third major resistance level sits at $2.75. If the price goes on to break the first support level at $2.15, it is likely to go to the next support level at $1.99. The third support level lies at $1.85 if the price breaches the second support level.
ProQR Therapeutics N.V (NASDAQ: PRQR) Key Stats
Market capitalization of the company is 244.09 million based on 105,213K outstanding shares. Right now, sales total 20,460 K and income totals -30,040 K. The company made 3,370 K in profit during its latest quarter, and -12,860 K in sales during its previous quarter.
